REMAP ECMO - Beta Receptor Modulation Trial
NCT06522594
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Cardiogenic Shock
Interventions
DRUG:
Esmolol
Sponsor
Erasmus Medical Center